Previous studies using animal models indicate that FABP4 plays a significant role in several aspects of metabolic syndrome, including insulin resistance, type 2 DM and atherosclerosis, through its action at the interface of metabolic and inflammatory pathways in adipocytes and macrophages [1]–[8]. Here, FABP4 is linked to Insulin resistance.